Sarah Ringuette has 22 years of experience in pharmaceutical development including the past 10 in regulatory affairs. Prior to Elevation, she was an Executive Director of Regulatory Affairs at Biohaven Pharmaceuticals and Head of Regulatory for the Kleo Pharmaceuticals subsidiary, Principal in ICON’s Strategic Regulatory Services consulting group and Global Regulatory Lead at Alexion and Bristol-Myers Squibb. She has led regulatory strategy for small molecules, biologics, and cell and gene therapies from pre-IND through market approval and post marketing in oncology, immunology, infectious disease, neurology, metabolic and compliment conditions and ophthalmology across rare, ultra rare and non-orphan indications. She has an MPH from Johns Hopkins University, a RAC from the Regulatory Affairs Professional Society and a BS from the George Washington University. Sarah resides in Farmington, CT where she hikes and skis with her family as much as possible and is often seen around the US at dance competitions and horse shows with her daughters.